Jonathan Lippy

1.5k citations

25 papers · 505 indexed · h-index 13

Impact in

Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods
Pharmacology
- Cholinesterase and Neurodegenerative Diseases

Papers in ⓘ

Genetics 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
Oncology 9
- Cytokine Signaling Pathways and Interactions 3

Co-authors: George L. Trainor (5 shared papers)Catherine R. Burton (2 shared papers)David R. Langley (2 shared papers)Gene M. Dubowchik (2 shared papers)Carol Krause (2 shared papers)Hong Xiao (2 shared papers)John E. Macor (2 shared papers)Kevin Kish (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)SLAS DISCOVERY (6 papers)Analytical Biochemistry (4 papers)Drug Discovery Today (2 papers)Journal of Medicinal Chemistry (2 papers)
Partner nations: United States Germany Sweden

In The Last Decade

Jonathan Lippy

25 papers receiving 488 citations

Peers

Countries citing papers authored by Jonathan Lippy

Since Specialization

Citations

This map shows the geographic impact of Jonathan Lippy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Lippy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Lippy more than expected).

Fields of papers citing papers by Jonathan Lippy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Lippy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Lippy. The network helps show where Jonathan Lippy may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Lippy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Lippy Line = papers co-authored together Jonathan Lippy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core Bioorganic & Medicinal Chemistry Letters ·Prasanna Sivaprakasam, Xiaojun Han, Rita L. Civiello, Swanee Jacutin-Porte, Kevin Kish, Matt Pokross, H.A. Lewis, Nazia Ahmed, Nicolas Szapiel, John A. Newitt, Eric T. Baldwin, Hong Xiao, Carol Krause, Hyunsoo Park, Michelle Nophsker, Jonathan Lippy, Catherine R. Burton, David R. Langley, John E. Macor, Gene M. Dubowchik	2015	100
2	Trends in Kinase Selectivity: Insights for Target Class-Focused Library Screening Journal of Medicinal Chemistry ·Shana Posy, Mark A. Hermsmeier, Wayne Vaccaro, Karl‐Heinz Ott, Gordon Todderud, Jonathan Lippy, George L. Trainor, Deborah A. Loughney, Stephen R. Johnson	2010	62
3	Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors Journal of Medicinal Chemistry ·Guanglin Luo, Ling Chen, Catherine R. Burton, Hong Xiao, Prasanna Sivaprakasam, Carol Krause, Yang Cao, Nengyin Liu, Jonathan Lippy, Wendy Clarke, Kimberly J. Snow, Joseph Raybon, Vinod Arora, Matt Pokross, Kevin Kish, H.A. Lewis, David R. Langley, John E. Macor, Gene M. Dubowchik	2016	56
4	Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones Biochemical Pharmacology ·Jovita Marcinkeviciene, Michael J. Rogers, Lisa M. Kopcho, Wenjun Jiang, Kathy Wang, Dennis J. Murphy, Jonathan Lippy, Steven Link, Thomas D.Y. Chung, Frank Hobbs, Tasir S. Haque, George L. Trainor, Andrew Slee, Andrew M. Stern, Robert A. Copeland	2000	46
5	Identification of a phenylacylsulfonamide series of dual Bcl-2/Bcl-xL antagonists Bioorganic & Medicinal Chemistry Letters ·Heidi L. Perez, Patrizia Banfi, J. A. Bertrand, Zhen-Wei Cai, James Grebinski, Kyoung Kim, Jonathan Lippy, Michele Modugno, Joseph G. Naglich, Robert J. Schmidt, Andrew J. Tebben, Paola Vianello, Donna Wei, Liping Zhang, Arturo Galvani, Louis J. Lombardo, R. M. Borzilleri	2012	29
6	Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and Janus kinase 2 (JAK2) Bioorganic & Medicinal Chemistry Letters ·Qingjie Liu, Douglas G. Batt, Jonathan Lippy, Neha Surti, Andrew J. Tebben, J.K. Muckelbauer, Lin Chen, Yongmi An, ChiehYing Chang, Matt Pokross, Zheng Yang, Haiqing Wang, James R. Burke, Percy H. Carter, Joseph A. Tino	2015	23
7	Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA Bioorganic & Medicinal Chemistry Letters ·Soong‐Hoon Kim, John S. Tokarski, Kenneth J. Leavitt, Brian E. Fink, Mark Salvati, Robert V. Moquin, Mary T. Obermeier, George L. Trainor, Gregory G. Vite, Linda K. Stadnick, Jonathan Lippy, Dan You, Matthew V. Lorenzi, Ping Chen	2007	19
8	Pyrazole and pyrimidine phenylacylsulfonamides as dual Bcl-2/Bcl-xL antagonists Bioorganic & Medicinal Chemistry Letters ·Gretchen M. Schroeder, Donna Wei, Patrizia Banfi, Zhen‐Wei Cai, Jonathan Lippy, Maria Menichincheri, Michele Modugno, Joseph G. Naglich, Becky Penhallow, Heidi L. Perez, John S. Sack, Robert J. Schmidt, Andrew J. Tebben, Chunhong Yan, Liping Zhang, Arturo Galvani, Louis J. Lombardo, R. M. Borzilleri	2012	18
9	An electrophoretic mobility shift assay for the identification and kinetic analysis of acetyl transferase inhibitors Analytical Biochemistry ·Caroline Fanslau, Donna L. Pedicord, Sujatha Nagulapalli, Hillary Gray, Suhong Pang, Lata Jayaraman, Jonathan Lippy, Yuval Blat	2010	15
10	A Scintillation Proximity Assay for RNA Detection Analytical Biochemistry ·Jianwei Liu, Patricia Feldman, Jonathan Lippy, Ekaterina V. Bobkova, Michael G. Kurilla, Thomas D.Y. Chung	2001	14
11	A rapid, homogeneous, fluorescence polarization binding assay for peroxisome proliferator-activated receptors alpha and gamma using a fluorescein-tagged dual PPARα/γ activator Analytical Biochemistry ·Ramakrishna Seethala, Rajasree Golla, Zhengping Ma, Hao Zhang, K O'Malley, Jonathan Lippy, Lin Cheng, Kasim A. Mookhtiar, Dennis Farrelly, Litao Zhang, Narayanan Hariharan, Peter T. W. Cheng	2007	13
12	Quantitative, High-Throughput Cell-Based Assays for Inhibitors of trkA Receptor Analytical Biochemistry ·Thelma S. Angeles, Jonathan Lippy, Shi Yang	2000	13
13	Conversion of carbazole carboxamide based reversible inhibitors of Bruton’s tyrosine kinase (BTK) into potent, selective irreversible inhibitors in the carbazole, tetrahydrocarbazole, and a new 2,3-dimethylindole series Bioorganic & Medicinal Chemistry Letters ·Qingjie Liu, Douglas G. Batt, Charu Chaudhry, Jonathan Lippy, Mark A. Pattoli, Neha Surti, Songmei Xu, Percy H. Carter, James R. Burke, Joseph A. Tino	2018	12
14	Structure-Based Design of Selective Janus Kinase 2 Imidazo[4,5-d]pyrrolo[2,3-b]pyridine Inhibitors ACS Medicinal Chemistry Letters ·Amy C. Hart, Gretchen M. Schroeder, Honghe Wan, James Grebinski, Jennifer Inghrim, James Kempson, Junqing Guo, William J. Pitts, John S. Tokarski, John S. Sack, Javed Khan, Jonathan Lippy, Matthew V. Lorenzi, Dan You, Theresa McDevitt, Ragini Vuppugalla, Yueping Zhang, Louis J. Lombardo, George L. Trainor, Ashok V. Purandare	2015	11
15	Leveraging the IncuCyte Technology for Higher-Throughput and Automated Chemotaxis Assays for Target Validation and Compound Characterization SLAS DISCOVERY ·Jing Chen, Bert Ribeiro, Han Li, Larnie Myer, Peter Chase, Neha Surti, Jonathan Lippy, Litao Zhang, Mary Ellen Cvijic	2017	10
16	9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors Bioorganic & Medicinal Chemistry Letters ·Kurt Zimmermann, Xiaopeng Sang, Harold Mastalerz, Walter L. Johnson, Guifen Zhang, Qingjie Liu, Douglas G. Batt, Louis J. Lombardo, Dinesh M. Vyas, George L. Trainor, John S. Tokarski, Matthew V. Lorenzi, Dan You, Marco M. Gottardis, Jonathan Lippy, Javed Khan, John S. Sack, Ashok V. Purandare	2015	10
17	A High-Throughput BRET Cellular Target Engagement Assay Links Biochemical to Cellular Activity for Bruton’s Tyrosine Kinase SLAS DISCOVERY ·Lianne Ong, James D. Vasta, Laura Monereau, Gregory Locke, Humberto Ribeiro, Mark A. Pattoli, Stacey Skala, James R. Burke, Scott H. Watterson, Joseph A. Tino, Poncho Meisenheimer, Brian J. Arey, Jonathan Lippy, L. Zhang, Matthew B. Robers, Andrew J. Tebben, Charu Chaudhry	2019	9
18	Leveraging text analytics in patent analysis to empower business decisions – A competitive differentiation of kinase assay technology platforms by I2E text mining software World Patent Information ·YiSi Yang, Thomas Klose, Jonathan Lippy, Cynthia Barcelon-Yang, Litao Zhang	2014	9
19	Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004–2009 Drug Discovery Today ·Litao Zhang, Mary Ellen Cvijic, Jonathan Lippy, James C. Myslik, Stephen L. Brenner, Alastair Binnie, John G. Houston	2012	7
20	Development of a Human Whole Blood Screening Platform to Monitor JAK/STAT Signaling Using High-Throughput Flow Cytometry SLAS DISCOVERY ·Mark Fereshteh, Xin Li, Sha Li, Yi Fan, Rosemary Zhang, Glen A. Farr, Garrett Kolodin, Jonathan Lippy, Joseph G. Naglich, Gary L. Schieven, Liang Schweizer, Litao Zhang	2016	6

About Jonathan Lippy

Jonathan Lippy is a scholar working on Genetics, Oncology, Computational Theory and Mathematics, Molecular Biology and Biophysics, having authored 25 papers that have together received 505 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (5 papers), Protein Degradation and Inhibitors (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Receptor Mechanisms and Signaling (3 papers), Single-cell and spatial transcriptomics (2 papers), Melanoma and MAPK Pathways (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Computational Theory and Mathematics (118 citations), Pharmacology (90 citations), Molecular Biology (349 citations), Organic Chemistry (124 citations) and Genetics (39 citations). Jonathan Lippy has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include George L. Trainor, Catherine R. Burton, David R. Langley, Gene M. Dubowchik, Carol Krause, Hong Xiao, John E. Macor, Kevin Kish, H.A. Lewis and Prasanna Sivaprakasam. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, SLAS DISCOVERY, Analytical Biochemistry, Drug Discovery Today and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact